©istock.com/Andrea Obzerova
Unsere KompetenzInterdisziplinäre Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patientinnen und Patienten.

Klinische FragestellungSifrim-Hitz-Weiss-Syndrom, Differentialdiagnose

Zusammenfassung

Kurzinformation

Gen-panel für Sifrim-Hitz-Weiss-Syndrom mit 1 "core"-Gen, 6 weiteren "core candidate"-Genen bzw. zusammen genommen 79 kuratierten Genen gemäß klinischer Verdachtsdiagnose

ID
SP9232
Anzahl Gene
79 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
33,8 kb (Core-/Core-canditate-Gene)
264,6 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GReferenz-Seq.Erbgang
ADNP3309NM_015339.5AD
CHD45739NM_001273.5AD
EHMT13897NM_024757.5AD
KANSL13318NM_001193466.2AD
KAT6A6015NM_006766.5AD
MED13L6633NM_015335.5AD
SETBP14791NM_015559.3AD, SMu
AP2M11400NM_004068.4AD
ARID1A6858NM_006015.6AD
ARID1B6750NM_001374820.1AD
ARID25508NM_152641.4AD
ASH1L8895NM_018489.3AD
AUTS23780NM_015570.4AD
BCL11A2322NM_018014.4AD
BRSK22211NM_001256627.2AD
CAMK2A1493NM_015981.4AD
CAMK2B2256NM_001220.5AD
CAMK2G1620NM_001204492.2AD
CDH152445NM_004933.3AD
CERT12259NM_001130105.1AD
CHAMP12439NM_001164144.3AD
CIC4827NM_015125.5AD
CLTC5111NM_004859.4AD
CSDE12397NM_001007553.3AD
CSNK2B665NM_001320.7AD
CTCF1200NM_006565.4AD
CTNNB12346NM_001904.4AD
CUX14518NM_001202543.2AD
DEAF11698NM_021008.4AD, AR
DLG42166NM_001128827.4AD
DPF21175NM_006268.5AD
DPP62406NM_001039350.3AD
DYNC1H113941NM_001376.5AD
DYRK1A2292NM_001396.5AD
EEF1A21392NM_001958.5AD
EPB41L12643NM_001258329.1AD
FOXP12034NM_032682.6AD
GATAD2B1782NM_020699.4AD
GNB11032NM_002074.5AD
GRIA43017NM_000829.4AD
GRIN2B4455NM_000834.5AD
HIVEP27341NM_006734.4AD
KCNQ52772NM_001160130.2AD
KDM4B4291NM_015015.3AD
KMT5B1182NM_017635.5AD
MBD54485NM_018328.5AD
MED136525NM_005121.3AD
MYT1L3555NM_015025.4AD
NAA152601NM_057175.5AD
NBEA2220NM_015678.5AD
NUS1887NM_138459.5AD, AR
PACS12892NM_018026.4AD
POGZ4233NM_015100.4AD
PPP2R1A1770NM_014225.6AD
PPP2R5D1356NM_006245.4AD
PURA969NM_005859.5AD
RAC1579NM_006908.5AD
RORA1647NM_002943.4AD
SCN8A5943NM_014191.4AD
SET1124NM_001122821.2AD
SETD54329NM_001080517.3AD
SMARCA45040NM_001128849.3AD
SMARCB11158NM_003073.5AD
SMARCC23459NM_003075.5AD
SMARCE11236NM_003079.5AD
SOX111326NM_003108.4AD
STAG13777NM_005862.3AD
SYNGAP14032NM_006772.3AD
SYT11277NM_005639.3AD
TAOK13025NM_020791.4AD
TBL1XR11545NM_024665.7AD
TBR12049NM_006593.4AD
TLK22372NM_006852.6AD
TRIM81796NM_030912.3AD
TRIO9294NM_007118.4AD
TRIP125979NM_004238.3AD
ZBTB181596NM_205768.3AD
ZMYND111647NM_006624.7AD
ZNF2928172NM_015021.3AD

Infos zur Erkrankung

Synonyme
  • Alias: CHD4 neurodevelopmental disorder
  • Allelic: Charcot-Marie-Tooth disease, axonal, type 20 (DYNC1H1)
  • Allelic: Exudative vitreoretinopathy 7 (CTNNB1)
  • Allelic: Meningioma, familial, susceptibility to (SMARCE1)
  • Allelic: Mental retardation, AR 63 (CAMK2A)
  • Allelic: Myoclonus, familial, 2 (SCN8A)
  • Allelic: Rhabdoid tumor predisposition syndrome 2 (SMARCA4)
  • Allelic: Schwannomatosis-1, susceptibility to (SMARCB1)
  • Allelic: Seizures, benign familial infantile, 5 (SCN8A)
  • Allelic: Spinal muscular atrophy, lower extremity-predominant 1, AD (DYNC1H1)
  • Arboleda-Tham syndrome (KAT6A)
  • Baker-Gordon syndrome (SYT1)
  • Coffin-Siris syndrome 1 (ARID1B)
  • Coffin-Siris syndrome 2 (ARID1A)
  • Coffin-Siris syndrome 3 (SMARCB1)
  • Coffin-Siris syndrome 4 (SMARCA4)
  • Coffin-Siris syndrome 5 (SMARCE1)
  • Coffin-Siris syndrome 6 (ARID2)
  • Coffin-Siris syndrome 7 (DPF2)
  • Coffin-Siris syndrome 8 (SMARCC2)
  • Coffin-Siris syndrome 9 (SOX11)
  • Cognitive impairment with/-out cerebellar ataxia (SCN8A)
  • Congenital disorder of glycosylation, type 1aa (NUS1)
  • Developmental + epileptic encephalopathy 13 (SCN8A)
  • Developmental + epileptic encephalopathy 27 (GRIN2B)
  • Developmental + epileptic encephalopathy 33 (EEF1A2)
  • Developmental delay with/-out intellectual impairment or behavioral abnormalities (TAOK1)
  • Dias-Logan syndrome (BCL11A)
  • Focal segmental glomerulosclerosis + neurodevelopmental syndrome (TRIM8)
  • GAND syndrome (GATAD2B)
  • Global developmental delay with/-out impaired intellectual development (CUX1)
  • Global developmental delay, ID, autism [panelapp] (CSDE1)
  • Global developmental delay, ID, autism, behavioral abnormality [panelapp] (BRSK2)
  • Helsmoortel-van der Aa syndrome (ADNP)
  • Impaired intellectual development, distinctive facial features with/-out cardiac defects (MED13L)
  • Intellectual developmental disorder 60 with seizures (AP2M1)
  • Intellectual developmental disorder 61 (MED13)
  • Intellectual developmental disorder 62 (DLG4)
  • Intellectual developmental disorder with autism + speech delay (TBR1)
  • Intellectual developmental disorder with/-out epilepsy or cerebellar ataxia (RORA)
  • Intellectual developmental disorder, AD 11 (EPB41L1)
  • Intellectual developmental disorder, AD 26 (AUTS2)
  • Intellectual developmental disorder, AD 42 (GNB1)
  • Intellectual developmental disorder, AD 44, with microcephaly (TRIO)
  • Intellectual developmental disorder, AD 50, with behavioral abnormalities (NAA15)
  • Intellectual developmental disorder, AD 6, with/-out seizures (GRIN2B)
  • Intellectual developmental disorder, AD 63, with macrocephaly (TRIO)
  • Intellectual developmental disorder, AD 64 (ZNF292)
  • Intellectual developmental disorder, AD 65 (KDM4B)
  • Kleefstra syndrome 1 (EHMT1)
  • Koolen-De Vries syndrome (KANSL1)
  • Mental retardation with language impairment with/-out autistic features (FOXP1)
  • Mental retardation, AD 1 (MBD5)
  • Mental retardation, AD 10 (CACNG2)
  • Mental retardation, AD 13 (DYNC1H1)
  • Mental retardation, AD 21 (CTCF)
  • Mental retardation, AD 22 (ZBTB18)
  • Mental retardation, AD 23 (SETD5)
  • Mental retardation, AD 29 (SETBP1)
  • Mental retardation, AD 3 (CDH15)
  • Mental retardation, AD 30 (ZMYND11)
  • Mental retardation, AD 33 (DPP6)
  • Mental retardation, AD 34 (CERT1 syn. COL4A3BP)
  • Mental retardation, AD 35 (PPP2R5D)
  • Mental retardation, AD 36 (PPP2R1A)
  • Mental retardation, AD 38 (EEF1A2)
  • Mental retardation, AD 39 (MYT1L)
  • Mental retardation, AD 40 (CHAMP1)
  • Mental retardation, AD 41 (TBL1XR1)
  • Mental retardation, AD 43 (HIVEP2)
  • Mental retardation, AD 45 (CIC)
  • Mental retardation, AD 46 (KCNQ5)
  • Mental retardation, AD 47 (STAG1)
  • Mental retardation, AD 48 (RAC1)
  • Mental retardation, AD 49 (TRIP12)
  • Mental retardation, AD 5 (SYNGAP1)
  • Mental retardation, AD 51 (KMT5B)
  • Mental retardation, AD 52 (ASH1L)
  • Mental retardation, AD 53 (CAMK2A)
  • Mental retardation, AD 54 (CAMK2B)
  • Mental retardation, AD 55, with seizures (NUS1)
  • Mental retardation, AD 56 (CLTC)
  • Mental retardation, AD 57 (TLK2)
  • Mental retardation, AD 58 (SET)
  • Mental retardation, AD 59 (CAMK2G)
  • Mental retardation, AD 7 (DYRK1A)
  • Neurodevelopmental disorder with hypotonia, impaired expressive language, +/- seizures (DEAF1)
  • Neurodevelopmental disorder with spastic diplegia + visual defects (CTNNB1)
  • Neurodevelopmental disorder with/-out early-onset generalized epilepsy (NBEA)
  • Neurodevelopmental disorder with/-out seizures + gait abnormalities (GRIA4)
  • Neurodevelopmental disorder, neonatal respiratory insufficiency, hypotonia, feeding diffic. (PURA)
  • Pierpont syndrome (TBL1XR1)
  • Poirier-Bienvenu neurodevelopmental syndrome (CSNK2B)
  • Rhabdoid tumor predisposition syndrome 1 (SMARCB1)
  • Schinzel-Giedion midface retraction syndrome (SETBP1)
  • Schuurs-Hoeijmakers syndrome (PACS1)
  • Vulto-van Silfout-de Vries syndrome (DEAF1)
  • White-Sutton syndrome (POGZ)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AR
  • SMu
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatik und klinische Interpretation

Kein Text hinterlegt